ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Diagnosing & Treating Hemophagocytic Lymphohistiocytosis in Adults

Srujana Pachigolla, MD, & Adegbenga Bankole, MD  |  June 15, 2020

Primary hemophagocytic lymphohistiocytosis (HLH) is caused by genetic mutations and inherited syndromes; it therefore occurs in the pediatric age group. Secondary HLH, however, is more common in adults and is often triggered by other disease states, such as malignancies, chronic immuno­suppression, infections and autoimmune disease.1,2 Macrophage activation syndrome (MAS) is a subset of secondary HLH…

Filed under:ConditionsVasculitis Tagged with:case reporthemophagocytic lymphohistiocytosishemophagocytic lymphohistiocytosis (HLH)HLHmacrophage activation syndrome

Ethics Forum: Medical Ethical Considerations for COVID-19

David Y. Chen, MD, PhD, & Eric J. Gapud, MD, PhD, on behalf of the ACR Committee for Ethics & Conflicts of Interest  |  June 8, 2020

Prescribing stewardship is just one ethical consideration facing rheumatologists during the COVID-19 pandemic.

Filed under:Ethics Tagged with:COVID-19Ethics Forum

Few Medicare Advantage Plans Cover Social Needs for Chronically Ill Patients

Lisa Rappaport  |  May 28, 2020

(Reuters Health)—Most Medicare Advantage plans are not offering chronically ill enrollees supplemental benefits to address social needs, which were added to the government health program in 2018 in an effort to improve health outcomes and achieve cost savings, a U.S. study suggests.1 Researchers examined publicly available data on benefits and plan design for Medicare Advantage…

Filed under:Conditions Tagged with:chronic illnessHealth InsuranceMedicareMedicare Advantage

Rheumatology Education Goes ViRL: New Online Courses Use Interactive Platforms to Engage Fellows

Susan Bernstein  |  May 26, 2020

Interactive rheumatology education has flourished online thanks to grassroots efforts & ACR support…

Filed under:Education & Training Tagged with:COVID-19FellowsFellows-in-TrainingTrainingViRLVirtual Rheumatology Learning Collaborative (ViRL)

Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis

Lara C. Pullen, PhD  |  May 18, 2020

Recent research examined the use of apremilast in patients with psoriatic arthritis using the Clinical Disease Activity in Psoriatic Arthritis (cDAPSA) measurement. The findings suggest patients with moderate disease activity at baseline benefit most from the treatment…

Filed under:ConditionsPsoriatic Arthritis Tagged with:apremilastcDAPSAClinical Disease Activity in Psoriatic Arthritis (cDAPSA)PsAPsoriatic Arthritis

Researchers Discuss Viability of Rheumatology Education During the COVID‐19 Pandemic

Arthritis & Rheumatology  |  May 15, 2020

In a matter of weeks, the COVID‑19 crisis has totally upended clinical medicine and the practice of rheumatology. Our old ways of seeing patients in person, precepting fellows in clinic or on the consult service, and leading in-person interactive teaching rounds are gone for now and possibly for good. But how can we replace these…

Filed under:Education & TrainingResearch Rheum Tagged with:Arthritis & RheumatologyCOVID-19ResearchSampling Rheum

Rheum After 5: Dr. Victoria Seligman Helps Create Cambodian Healthcare

Carol Patton  |  May 15, 2020

In 2001, Victoria Seligman, MD, MPH, was vacationing in Vietnam. While traveling by train, she met a student from Yale University who was working on the school’s Cambodian Genocide Program, which documents the atrocities that occurred in Cambodia between 1975 and 1979 under the Khmer Rouge regime. Approximately 1.7 million people—representing 21% of the population—were slaughtered….

Filed under:ProfilesRheum After 5 Tagged with:Dr. Victoria SeligmanHealth Volunteers Overseas

Andrey_Popov / shutterstock.com

Rheumatology & Digital Wearables: What’s on the Horizon?

Carina Stanton  |  May 15, 2020

SNOWMASS VILLAGE, COLO.—A major workforce shortage, a population of patients taking immunosuppressants where safety concerns and the patient experience are critical, and an increasing focus on remote patient monitoring and telehealth are driving a discussion regarding the role digital wearables play in rheumatologic care. “We need to be more thoughtful and efficient in taking care…

Filed under:AppsTechnologyWorkforce Tagged with:digital wearablespatient datatelehealthWinter Rheumatology Summitworkforce shortage

Sentavio / shutterstock.com

Rheumatoid Arthritis Therapy Update: What’s Changed & What’s the Same

Kimberly Retzlaff  |  May 15, 2020

SNOWMASS VILLAGE, COLO.—Current trends in rheumatoid arthritis (RA) therapy are the increased use of newer medication categories, such as Janus kinase (JAK) inhibitors (Jakinibs) and biologics, and the rising costs of treatment. Unchanged is the consistent use of methotrexate as an effective therapy. These topics and more were discussed at the ACR Winter Symposium during…

Filed under:Biologics/DMARDsConditionsRheumatoid Arthritis Tagged with:costsjanus kinase inhibitorMethotrexateWinter Rheumatology Summit

The Potential for Telemedicine to Supplement In-Person Care

Elizabeth Park, MD  |  May 15, 2020

Even before I started my rheuma­tology fellowship, I knew it would be a demanding career, diagnosing complex diseases with only a few management options in seriously ill patients. What I didn’t appreciate as much before is how badly we are needed across the country. According to the 2018 outcomes report from the National Resident Matching…

Filed under:Practice SupportTechnology Tagged with:Fellows-in-Trainingtelemedicinetelerheumatology

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences